Paper Details

  1. Home
  2. Paper Details

Teduglutide for the treatment of short bowel syndrome.

Author: JeppesenP B

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

This monograph reviews the preclinical and clinical data supporting the use of teduglutide, a GLP-2 analogue, for the treatment of short bowel syndrome (SBS).
Paper Details　
Original Abstract of the Article :
Glucagon-like peptide 2 (GLP-2) decreases gastric and intestinal motility, reduces gastric secretions, promotes intestinal growth and improves post-resection structural and functional adaptation in short bowel syndrome (SBS). Teduglutide, an analogue of GLP-2, has a prolonged half-life and provides ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1358/dot.2013.49.10.2017025

データ提供：米国国立医学図書館（NLM）

Teduglutide: A New Oasis for Short Bowel Syndrome

Short bowel syndrome (SBS) is a challenging condition, often requiring significant medical intervention. This study explores the role of teduglutide, a synthetic analogue of glucagon-like peptide 2 (GLP-2), as a potential treatment for SBS. It's like venturing into the desert of SBS research, seeking new and effective solutions for this complex condition.

Teduglutide: A New Hope for SBS Patients

The researchers highlight the benefits of teduglutide in managing SBS, emphasizing its ability to promote intestinal growth, reduce the need for parenteral support, and improve overall quality of life for patients. This discovery is like finding a hidden oasis in the desert - a source of hope for those living with SBS.

Navigating the Desert of SBS: A Promising New Treatment

The study's findings suggest that teduglutide could offer a significant improvement in the management of SBS, offering a new paradigm for treating this challenging condition. It's like finding a new path in the desert - a route towards a more effective and less burdensome approach to SBS management.

Dr. Camel's Conclusion

This study highlights the potential of teduglutide as a promising new treatment for SBS. The researchers' findings offer a glimmer of hope for improving the lives of individuals living with this complex condition. It's like discovering a new oasis in the desert - a place where we can find effective solutions for those struggling with SBS.

Date :
  1. Date Completed 2014-01-15
  2. Date Revised 2017-11-16
Further Info :

Pubmed ID

24191254

DOI: Digital Object Identifier

10.1358/dot.2013.49.10.2017025

Related Literature

Article Analysis
・Effects of teduglutide injection
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.